Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Terminated
×
Peripheral Nervous System Diseases
×
Clear all
Filters
3
NCT04034355
2022-01-26
POLAR-A
Egetis Therapeutics
Phase 3
Terminated
301 enrolled
18 charts